Contradiction in Harzard ratio and Log fold change
1
0
Entering edit mode
24 days ago
Mran ▴ 20

Hi there. I am working on a pan-cancer project that contains 12 cancers. The data in use is TCGA RNA-seq data. I have found 37 genes that are involved in survival of patients.I performed a Differential expression between normal and cancer patients. then I have performed a CoxPH model between Dead and Alive Cancer patients on selected genes. dead = 1 and survive= 0.

I calculated LogFC of each gene expression between cancer and normal.

I know that genes with Posetive LogFC and +1 HR are known as bad prognostic. also genes with negative LogFC and 0<HR<1 are known as good prognostic.

but my Problem is, that some genes contain negative Log FC and +1 HR or posetive LogFC wirh HR value less than 1. what does it mean? Thanks

Foldchange Cancer HR HarzardRatio LogFC • 251 views
ADD COMMENT
2
Entering edit mode
23 days ago

Hi,

There is no issue here, in my opinion.

Consider the following 3 scenarios:

  • a tumour suppressor gene is deleted or heavily methylated, and its expression via RNA-seq is then virtually 0 (negative log [base 2] fold-change). This results in an increased risk of death (HR > 1).
  • an oncogene 'driver' is amplified or has its expression increased via some other mechanism, and its expression via RNA-seq is then increased (positive log [base 2] fold-change). This also results in an increased risk of death (HR > 1).
  • we observe increased B-cell and macrophage infiltration in the tumour nest, with corresponding increase in genes related to these, including CD20, MS4A1, and CD68 (positive log [base 2] fold change). This is protective (HR<1).

However, as with everything in cancer, there are 'double edged swords' in every which way that we look...

Kevin

ADD COMMENT
1
Entering edit mode

Thank you so much. I think so, that some signaling pathways are involved here specially some regulators like Tumor suppressors and oncogenes.

ADD REPLY

Login before adding your answer.

Traffic: 1588 users visited in the last hour
Help About
FAQ
Access RSS
API
Stats

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6